GenPAx

Gstaad, Switzerland

Genome analysis for pathogens, Biotech, SaaS.

$2.9M raised

Mar 2022

Seed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about GenPAx

How much funding has GenPAx raised?

GenPAx has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in March 2022.

Where is GenPAx headquartered?

GenPAx is headquartered in Gstaad, Switzerland.

What does GenPAx do?

Genome analysis for pathogens, Biotech, SaaS.

What stage is GenPAx at?

GenPAx is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 1, 2022.

MLA

"GenPAx — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/genpax. Accessed July 2, 2026.

APA

VCBacked. (2022). GenPAx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/genpax

Wikipedia (cite web)

{{cite web |title=GenPAx — Funding & Investors |url=https://www.vcbacked.co/company/genpax |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 1, 2022.